Previous studies have demonstrated that MMP-9 expression is upregulated in acute kidney injury, interstitial fibrosis, glomerulonephritis, and diabetic nephropathy [42]; therefore, MMP-9 inhibition by naringenin could attenuate tissue damage and prevent crystal nucleation, contributing to an anti-urolithiatic effect. Here, MMP9 is linked to glomerulonephritis.